Exchange Traded Concepts’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-68,858
| Closed | -$101K | – | 1392 |
|
|
2025
Q1 | $101K | Buy |
68,858
+8,183
| +13% | +$11.9K | ﹤0.01% | 1157 |
|
|
2024
Q4 | $129K | Hold |
60,675
| – | – | ﹤0.01% | 1090 |
|
|
2024
Q3 | $170K | Buy |
60,675
+12,328
| +25% | +$34.5K | ﹤0.01% | 1010 |
|
|
2024
Q2 | $113K | Sell |
48,347
-15,042
| -24% | -$35K | ﹤0.01% | 932 |
|
|
2024
Q1 | $283K | Buy |
63,389
+27,349
| +76% | +$122K | 0.01% | 827 |
|
|
2023
Q4 | $116K | Buy |
36,040
+9,139
| +34% | +$29.3K | ﹤0.01% | 871 |
|
|
2023
Q3 | $85.3K | Buy |
26,901
+1,964
| +8% | +$6.23K | ﹤0.01% | 951 |
|
|
2023
Q2 | $124K | Buy |
+24,937
| New | +$124K | ﹤0.01% | 899 |
|